Thus, it is not surprising that NAFLD-related polymorphism sites also have been found in insulin-related genes, such as IRS2 (insulin receptor substrate 2) and IGF1 (insulin-like growth factor 1). This evidence concerns the gene IRS2 and metabolic dysfunction-associated steatotic liver disease.